| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880fdd58fb74dc19b8025af4de7153af |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0160844769a99dcde91a8e01bb305a9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7994940f1933d00bc80d809ed39270a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc34eaa7cb6dc61891f4434ab58172a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_424ea2d2275f455e37d981c698ec20c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77df78ffe3a1680e47195c94323a57f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3b09f559a7d0eff32a60589563183fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4717fc7c073170c51d85fee5ed09c346 |
| publicationDate |
2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140137681-A |
| titleOfInvention |
Pharmaceutical composition comprising n1-cyclic amine-n5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis |
| abstract |
The present invention provides a novel use of N1-ring amine-N5-substituted bi-guanidine derivatives for the preparation of medicaments for preventing or treating fibrosis. The N1-cyclic amine-N5-substituted biguanide derivatives according to the present invention effectively inhibit EMT, thereby effectively suppressing fibrosis. [Chemical Formula 1] |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018139828-A1 |
| priorityDate |
2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |